LivaNova PLC

Common Name

LivaNova

Country

United Kingdom

Sector

Healthcare

Industry

Medical Devices

Employees

2,900

Ticker

LIVN

Exchange

NASDAQ/NGS

Website

www.livanova.com

Description

LivaNova PLC is a global medical technology company that focuses on developing and delivering innovative medical devices for cardiac surgery and neuromodulation. With its headquarters situated in Lond... Show more

Financial Statements of LivaNova

Below are the financial statements of LivaNova, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	428.86^a	266.5^a
Restricted cash	294.7^a	311.37^a
Accounts receivable, net of allowance of $11,275 at December 31, 2024 and $12,019 at December 31, 2023	193.16^a	215.07^a
Inventories	147.57^a	147.89^a
Prepaid and refundable taxes	30.54^a	20.15^a
Prepaid expenses and other current assets	32.36^a	27.18^a
Total current assets	1,127.19^a	988.16^a
Assets	—	—
Property, plant, and equipment, net	170.26^a	154.18^a
Goodwill	750.01^a	782.94^a
Intangible assets, net	237.29^a	261.18^a
Operating lease assets	46.84^a	50.85^a
Investments	25.08^a	22.84^a
Deferred tax assets	111.86^a	118.86^a
Long-term derivative assets	23.74^a	38.5^a
Other assets	14.13^a	12.06^a
Total assets	2,506.39^a	2,429.56^a
Current liabilities	—	—
Current debt obligations	78^a	18.11^a
Accounts payable	69.73^a	80.85^a
Accrued liabilities and other	118.49^a	107.3^a
Current litigation provision liability	12.92^a	10.76^a
Taxes payable	32.46^a	23.34^a
Accrued employee compensation and related benefits	80.54^a	94.63^a
Total current liabilities	392.13^a	334.98^a
Liabilities and stockholders’ equity	—	—
Long-term debt obligations	549.62^a	568.54^a
Contingent consideration	84.22^a	80.9^a
Deferred tax liabilities	10.92^a	11.57^a
Long-term operating lease liabilities	40.11^a	45.39^a
Long-term employee compensation and related benefits	12.85^a	17.25^a
Long-term derivative liabilities	51.82^a	45.57^a
Other long-term liabilities	44.48^a	47.73^a
Total liabilities	1,186.13^a	1,151.94^a
Stockholders’ equity	—	—
Ordinary shares	83.16^a	82.53^a
Additional paid-in capital	2,220.66^a	2,189.52^a
Accumulated other comprehensive loss	-80.17^a	-27.88^a
Accumulated deficit	-903.25^a	-966.48^a
Treasury stock at cost	-0.14^a	-0.06^a
Total stockholders’ equity	1,320.26^a	1,277.63^a
Total liabilities and stockholders’ equity	2,506.39^a	2,429.56^a

Verified Sources Behind LivaNova’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore LivaNova’s data sources below and access millions more through our Disclosure Search.

a. LivaNova's 10-K 2024

Trace every data point back to LivaNova’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

LivaNova PLC

Financial Statements of LivaNova

Verified Sources Behind LivaNova’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Smith & Nephew PLC

Verona Pharma PLC

AstraZeneca PLC

GSK plc

Haleon PLC

ConvaTec Group PLC